Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Morphosys AG (DE:MOR)
XETRA:MOR
Holding DE:MOR?
Track your performance easily
MOR Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€26.89 - €69.75
Previous Close€67.75
Volume0.00
Average Volume (3M)3.21K
Market Cap
€2.55B
Enterprise Value€2.65B
Total Cash (Recent Filing)€158.50M
Total Debt (Recent Filing)€256.45M
Price to Earnings (P/E)―
Beta0.36
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.69
Shares Outstanding34,160,673
10 Day Avg. Volume10,461
30 Day Avg. Volume3,207
Standard Deviation0.17
R-Squared0.02
Alpha0.00329
Financial Highlights & Ratios
Price to Book (P/B)1120.83
Price to Sales (P/S)4.59
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€68.00Price Target Upside0.37% Upside
Rating ConsensusHold
Number of Analyst Covering1
Morphosys News
PremiumCompany Announcements
MorphoSys AG Joins Forces with Novartis
PremiumCompany Announcements
MorphoSys Shareholders Approve Novartis Merger
MOR FAQ
What was Morphosys AG’s price range in the past 12 months?
Morphosys AG lowest stock price was €26.89 and its highest was €69.75 in the past 12 months.
What is Morphosys AG’s market cap?
Currently, no data Available
When is Morphosys AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Morphosys AG’s earnings last quarter?
Currently, no data Available
Is Morphosys AG overvalued?
According to Wall Street analysts Morphosys AG’s price is currently Undervalued.
Does Morphosys AG pay dividends?
Morphosys AG does not currently pay dividends.
What is Morphosys AG’s EPS estimate?
Morphosys AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Morphosys AG have?
Morphosys AG has 37,716,427 shares outstanding.
What happened to Morphosys AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Morphosys AG?
Currently, no hedge funds are holding shares in DE:MOR
---
Morphosys Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Morphosys AG
MorphoSys AG is a biotechnology company that develops therapeutic antibodies. The company reports two business segments: partnered discovery and proprietary development. Its partnered discovery segment applies the research, development, and optimization of antibody-drug candidates in partnerships with pharmaceutical and biotechnology companies. MorphoSys' profits in this segment stem from successful programs via milestone payments and potential royalties on product sales. In its proprietary development segment, the company develops antibodies that concentrate on inflammatory and autoimmune diseases, as well as cancer and infectious diseases.
---
MOR Stock 12 Month Forecast
Average Price Target
€68.00
▲(0.37% Upside)
Technical Analysis
Best Analysts Covering MOR
1 Year
1 Year Success Rate
10/27 ratings generated profit
1 Year Average Return
-6.17%
reiterated a buy rating 11 months ago
Copying James Gordon's trades and holding each position for 1 Year would result in 37.04% of your transactions generating a profit, with an average return of -6.17% per trade.
---